|
![]() |
|||
|
||||
OverviewAs governments seek to mitigate the cost of state subsidized healthcare, branding in the pharmaceutical industry has become a critical issue. Drugs companies must change their methods of communication and distribution focusing more on their direct relationship with the consumer. This requires fundamental changes in consumer behaviour, access to information, freedom of choice and value for money. Brands and brand values will play a leading role in this process, as has been seen with products such as Prozac and Viagra. This book by Interbrand Newell and Sorrell provides thinking on branding for the pharmaceutical industry and lessons for anyone involved in brand development and management. Full Product DetailsAuthor: T. Blackett , R. Robins , Tom Blackett , Rebecca RobinsPublisher: Palgrave Macmillan Imprint: Palgrave Macmillan Dimensions: Width: 15.20cm , Height: 2.50cm , Length: 22.90cm Weight: 0.638kg ISBN: 9780333930984ISBN 10: 0333930983 Pages: 308 Publication Date: 27 April 2001 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTOM BLACKETT is Group Deputy Chairman of Interbrand Newell and Sorrell. He is the author of, Trademarks and the co-author of, Co-Branding, both published by Palgrave. - REBECCA ROBINS works for Interbrand Newell and Sorrell Tab Content 6Author Website:Countries AvailableAll regions |